Verve Therapeutics Inc (VERV)
5.20
+0.06
(+1.17%)
USD |
NASDAQ |
May 31, 16:00
5.20
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Profit Margin (Quarterly): -855.8% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -855.8% |
| December 31, 2023 | -940.0% |
| September 30, 2023 | -1.47K% |
| June 30, 2023 | -2.58K% |
| Date | Value |
|---|---|
| March 31, 2023 | -3.70K% |
| December 31, 2022 | -4.06K% |
| September 30, 2022 | -4.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.86K%
Minimum
Sep 2022
-855.8%
Maximum
Mar 2024
-2.64K%
Average
-2.58K%
Median
Jun 2023
Profit Margin (Quarterly) Benchmarks
| Acorda Therapeutics Inc | -135.0% |
| Eli Lilly and Co | 25.58% |
| Beam Therapeutics Inc | -1.33K% |
| Prime Medicine Inc | -7.74K% |
| Gritstone Bio Inc | -82.42K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -37.60% |
| Return on Assets | -29.63% |
| Return on Invested Capital | -37.60% |
| Operating Margin (Quarterly) | -998.1% |
| Return on Net Operating Assets | -175.9% |